Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.
Reprogram Biosciences has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Reprogram Biosciences is headquartered in San Francisco, United States.
Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology.
Reprogram Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reprogram Biosciences — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/reprogram-biosciences. Accessed August 13, 2026.
VCBacked. (2026). Reprogram Biosciences — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/reprogram-biosciences
{{cite web |title=Reprogram Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/reprogram-biosciences |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated